Konstantinos Asimakopoulos
About Konstantinos Asimakopoulos
Konstantinos Asimakopoulos is a Medical Science Liaison in Oncology at Bristol Myers Squibb, with over a decade of experience in the pharmaceutical and healthcare industry.
Title
Konstantinos Asimakopoulos holds the title of Medical Science Liaison-Oncology at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Konstantinos Asimakopoulos currently works as a Medical Science Liaison-Oncology at Bristol Myers Squibb in Athens, Attiki, Greece. In this role, he focuses on bridging the gap between clinical practice and pharmaceutical research, emphasizing oncology.
Previous Experience at Bristol Myers Squibb
From 2020 to 2021, Konstantinos Asimakopoulos served as Senior Product Specialist at Bristol Myers Squibb in Athens. During his tenure, he was responsible for product management, which built the foundation for his current role in medical science liaison.
Professional Journey at Roche
Konstantinos Asimakopoulos spent four years working as a Medical Representative at Roche from 2016 to 2020 in Athens. This role involved detailed medical representation and interaction with healthcare professionals, laying the groundwork for his career in pharmaceutical medical science.
Early Career at Merck Group
Between 2012 and 2016, Konstantinos Asimakopoulos worked as a Product Specialist at Merck Group in Athens. This position marked the beginning of his journey in the pharmaceutical industry, where he gained initial experience in product specialization and pharmaceutical sales.
Education and Expertise
Konstantinos Asimakopoulos studied Biochemistry and Molecular Biology at the University of Thessaly from 2002 to 2006. His educational background has provided him with a deep understanding of biochemistry and molecular processes, essential for his roles in the pharmaceutical industry, particularly in oncology.
Background in Pharmaceutical Industry
Starting his career in 2012, Konstantinos Asimakopoulos has accumulated over a decade of experience in the pharmaceutical and healthcare industry. He has held various roles in major pharmaceutical companies such as Roche, Merck Group, and Bristol Myers Squibb, gaining significant expertise in medical representation, product specialization, and oncology.